-
11 July 2025 15:48:23
- Source: Sharecast
11 July 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 11 July 2025 that Richard Fairman, Chief Executive Officer of the Company, purchased a total of 1,644 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.
As a result, Richard Fairman's total interest in the Company, including all persons closely associated, is now at 79,751 Ordinary Shares, representing 0.111% per cent of the total voting rights of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Richard Fairman |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
PDMR (CEO) |
||||
|
b)
|
Initial notification /Amendment
|
Initial Notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
CVS Group plc |
||||
|
b)
|
LEI
|
213800J41XDQ2NX48O05 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary shares of 0.2 pence each
GB00B2863827
|
||||
|
b)
|
Nature of the transaction
|
On-market purchase |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d)
|
Aggregated information
- Aggregated volume
- Price
|
N/A - single transaction |
||||
|
e)
|
Date of the transaction
|
11 July 2025 |
||||
|
f)
|
Place of the transaction
|
London Stock Exchange - AIM (XLON) |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.